Back to Search
Start Over
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
- Source :
-
Haematologica [Haematologica] 2018 Nov; Vol. 103 (11), pp. e519-e521. Date of Electronic Publication: 2018 May 24. - Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 103
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 29794147
- Full Text :
- https://doi.org/10.3324/haematol.2018.193151